R3i-Stiftung - Residual Risk Reduction Initiative
ExistenteCH27070030171
Die Stiftung bezweckt, zur Förderung des Allgemeinwohls weltweit Anstrengungen zu unternehmen, das trotz kunstgerechter Behandlung verbleibende Restrisiko makro- und mikrovaskulärer Vorfälle bei Herz-Kreislauf- und Diabetes-Patienten zu reduzieren.
Información básica
| Forma legal | Foundation |
|---|---|
| Resumen | The company's purpose is to reduce the risk of macro- and microvascular events in patients with heart, circulatory, and diabetes conditions. This suggests that the company may be involved in manufacturing medical devices or providing healthcare services. |
Dirección
| Nombre de la empresa | R3i-Stiftung - Residual Risk Reduction Initiative |
|---|---|
| Código postal | 4052 |
| Ciudad | Basel |
| Cantón | Basel-Stadt |
| País | Switzerland |
Actividades comerciales
Human Health and Social Work ActivitiesManufacturing
Información de contacto
| Sitio web | https://r3i.org |
|---|
Información adicional
| Registrado | 20.9.2025 |
|---|---|
| Entrada del registro mercantil | CH27070030171 |
| Última actualización | 13.12.2025 |